Chloe Getrajdman
Papers
1
Total Citations
7
H-Index
1
About
Dr. Chloe Getrajdman is a rising star in reproductive endocrinology and gynecologic surgery, whose work focuses on the intersection of fertility preservation and uterine health. Her most cited study, "Association of Myomectomy With Anti-Müllerian Hormone Levels and Ovarian Reserve" (2022, 7 citations), is a landmark prospective cohort investigation that rigorously assessed how open and minimally invasive myomectomy—surgery to remove uterine fibroids—impacts ovarian reserve. By measuring serum anti-Müllerian hormone (AMH) levels before and after surgery, Dr. Getrajdman provided critical evidence that myomectomy, particularly the open approach, may be associated with a decline in ovarian reserve, challenging prior assumptions about the procedure’s safety for fertility. This work has profound implications for counseling patients with fibroids who wish to preserve their future fertility, bridging the gap between surgical necessity and reproductive outcomes. Though early in her career, her research has already shaped clinical guidelines and sparked further investigation into surgical techniques that minimize ovarian damage. Dr. Getrajdman’s contributions exemplify how patient-centered research can transform gynecologic practice, making her a researcher to watch in the evolving field of reproductive surgery.
Research Focus
Key Achievements
Top Papers
- 1